TROY, Mich., March 28, 2025 (GLOBE NEWSWIRE) -- Conifer Holdings, Inc. (Nasdaq: CNFR) (“Conifer” or the “Company”) today announced results for the fourth quarter and year ended December 31, 2024.

In April 2024, Entera announced that the Journal of Bone and Mineral Research (JBMR) published EB613 placebo controlled Phase 2 Trial results, highlighting its dual mechanism of action and rapid ...

Q4 2024 Earnings Call Transcript March 26, 2025 MicroVision, Inc. misses on earnings expectations. Reported EPS is $-0.14 EPS ...

Q4 2024 Earnings Call Transcript March 26, 2025 Dyadic International, Inc. misses on earnings expectations. Reported EPS is $ ...

Q4 2024 Earnings Call Transcript March 26, 2025 Journey Medical Corporation beats earnings expectations. Reported EPS is ...

Preliminary efficacy data from Phase 1/2 dose expansion cohort show durable responses and tumor shrinkage in a PD-(L)1 resistant “hot” tumor ...

The Company’s financial statements and related footnotes will be available in its Annual Report on Form 10-K for the year ended December 31, 2024, which is expected to be filed with the U.S.

Revenue and Growth While Executing on Strategic Acquisitions and Initiatives - - Fourth Quarter 2024 Total Revenue ...

Second AirSCWO Deploying to Orange County, CA in 2025, Multiple Additional Deployments Scheduled throughout 2025 to Showcase AirSCWOSuccessful ...

Iridex Corporation (Nasdaq: IRIX), a worldwide leader providing innovative and versatile laser-based medical systems, delivery devices, and procedure probes for the treatment of glaucoma and retinal ...

Inspire Veterinary Partners, Inc. (NASDAQ:IVP) (”Inspire” or the “Company”), an owner and provider of pet health care ...